Skip to content

Liquidia Corporation LQDA Total costs & expenses

Total costs & expenses at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$363.52M+30.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$300.47M+36.0%
TG Therapeutics logo
TG TherapeuticsTGTX
$170.12M+51.6%
Alkermes logo
AlkermesALKS
$441.19M+50.7%
United Therapeutics logo
United TherapeuticsUTHR
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$6.32B+164%
Enterprise value$6.1B+184%
P/S21.9×-147×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Liquidia Corporation’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Liquidia Corporation's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Liquidia Corporation's total costs & expenses?
Liquidia Corporation (LQDA) reported total costs & expenses of $71.36M in Q1 2026.
How has Liquidia Corporation's total costs & expenses changed year-over-year?
Liquidia Corporation's total costs & expenses increased by 85.1% year-over-year, from $38.55M to $71.36M.
What is the long-term trend for Liquidia Corporation's total costs & expenses?
Over 4 years (2021 to 2025), Liquidia Corporation's total costs & expenses has grown at a 45.6% compound annual growth rate (CAGR), from $46.65M to $209.7M.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating and non-operating costs incurred by the company during a specific reporting period. It encompasses research and development investments, selling, general, and administrative overhead, and other operational expenditures required to sustain business activities. Monitoring this figure provides insight into the company's overall cost structure and its ability to manage expenditures relative to revenue generation.